Hydrogen sulfide: from the smell of the past to the mediator of the future?: from the smell of the past to the mediator of the future?
Shabbir Moochhala, Philip K. Moore, Madhav Bhatia
pág. 609
pág. 611
Interleukin 4 treatment of psoriasis: are pleiotropic cytokines suitable therapies for autoimmune diseases?: are pleiotropic cytokines suitable therapies for autoimmune diseases?
Roland Martin
pág. 613
Sparing animals and progressing in science.
Stefania Filippeschi, Silvio GARATTINI, Amalia Guaitani
pág. 616
Fundamental molecular mechanism of the CNS effects of TRH.
George G. Yarbrough
pág. 617
Assessing predictors of drug-induced torsade de pointes.
Luiz Belardinelli, Charles Antzelevitch, Marc A. Vos
pág. 619
Non-visual GRKs: are we seeing the whole picture?: are we seeing the whole picture?
Jonathon M. Willets, Stefan R. Nahorski, R.A. John Challiss
pág. 626
Opioid hyperalgesia and tolerance versus 5-HT<sub>1A</sub> receptor-mediated inverse tolerance.
Zsuzsanna Wiesenfeld-Hallin, Francis Colpaert, Xiao-Jun Xu
pág. 634
Einar E. Eriksson, Lennart Lindbom, Holger Ulbrich
pág. 640
pág. 648
Techniques: Plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions.: Plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions.
Zdzislaw Salamon, Victor J. Hruby, Gordon Tollin
pág. 655
© 2001-2024 Fundación Dialnet · Todos los derechos reservados